In 2011, Pfizer announced a novel clinical trial that would be fully remote, with every aspect of the trial being handled either online, over the phone, or by mail. But that trial was cancelled due to a failure to recruit enough participants, and a promised mulligan never emerged. Craig Lipset, Pfizer’s Head of Clinical Innovation, said […]
from mobihealthnews http://ift.tt/1GP1WBH
via IFTTT